Search Results - "Imbergamo, Silvia"

Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy by Visentin, Andrea, Compagno, Nicolò, Cinetto, Francesco, Imbergamo, Silvia, Zambello, Renato, Piazza, Francesco, Semenzato, Gianpietro, Trentin, Livio, Agostini, Carlo

Get full text

Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients by Briani, Chiara, Visentin, Andrea, Salvalaggio, Alessandro, Imbergamo, Silvia, Piazza, Francesco, Cacciavillani, Mario, Campagnolo, Marta, Frezzato, Federica, Semenzato, Gianpietro, Trentin, Livio

Get full text

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency by Visentin, Andrea, Molinari, Maria Chiara, Pravato, Stefano, Cellini, Alessandro, Angotzi, Francesco, Cavaretta, Chiara Adele, Ruocco, Valeria, Imbergamo, Silvia, Piazza, Francesco, Proietti, Giulia, Mauro, Francesca Romana, Trentin, Livio

“…Secondary antibody deficiency (SAD) is a common complication in chronic lymphocytic leukemia (CLL) which favors the development of life-threatening infections…”
Get full text

Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network by Del Principe, Maria Ilaria, Buzzatti, Elisa, Piciocchi, Alfonso, Forghieri, Fabio, Bonifacio, Massimiliano, Lessi, Federica, Imbergamo, Silvia, Orciuolo, Enrico, Rossi, Giovanni, Fracchiolla, Nicola, Trappolini, Silvia, Neri, Benedetta, Sarlo, Chiara, Zappasodi, Patrizia, Dargenio, Michelina, Cefalo, Mariagiovanna, Irno-Consalvo, Maria Antonietta, Conti, Consuelo, Paterno, Giovangiacinto, De Angelis, Gottardo, Sciumè, Mariarita, Della Starza, Irene, Venditti, Adriano, Foà, Robin, Guarini, Anna Rita

“…In acute lymphoblastic leukemia, flow cytometry detects more accurately leukemic cells in patients' cerebrospinal fluid compared to conventional cytology…”
Get full text

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies by Angotzi, Francesco, Petrella, Marco, Berno, Tamara, Binotto, Gianni, Bonetto, Giorgia, Branca, Antonio, Carraro, Marco, Cavaretta, Chiara Adele, Cellini, Alessandro, D'Amore, Fabio, Forlani, Laura, Gianesello, Ilaria, Gurrieri, Carmela, Imbergamo, Silvia, Lessi, Federica, Maroccia, Antonio, Mazzetto, Federica, Pavan, Laura, Pezone, Sara, Piazza, Francesco, Pravato, Stefano, Ruocco, Valeria, Scapinello, Greta, Vianello, Fabrizio, Zambello, Renato, Zatta, Ivan, Zoletto, Simone, Padoan, Andrea, Trentin, Livio, Visentin, Andrea

“…The approved combination of Tixagevimab/Cilgavimab has been shown to decrease the rate of symptomatic SARS-CoV-2 infection in patients at increased risk of…”
Get full text

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia by Rizzuto, Giuliana, Leoncin, Matteo, Imbergamo, Silvia, Taurino, Daniela, Mico, Maria Caterina, Tosi, Manuela, Michelato, Anna, Buklijas, Ksenija, Spinelli, Orietta, Lussana, Federico, Lessi, Federica, Pizzi, Marco, Bonaldi, Laura, Binotto, Gianni, Rambaldi, Alessandro, Gurrieri, Carmela

“…The translocation t(8;9)(p22;p24) results in the production of a chimeric PCM1‐JAK2 fusion protein leading to the constitutive activation of the Janus Kinase 2…”
Get full text

Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center by Sartori, Maria Teresa, Imbergamo, Silvia, Zanon, Ezio, Bonaccorso, Giuseppina, Pittoni, Giovanni, Feltracco, Paolo, Ori, Carlo, Pagnan, Antonio, Cella, Giuseppe

“…Recombinant activated factor VII (rFVIIa) has been successfully used ''off-label'' in patients with refractory life-threatening hemorrhage. Intravenous rFVIIa…”
Get more information

Multifocal recurrent neuralgic amyotrophy in an immunocompromised patient by Briani, Chiara, Salvalaggio, Alessandro, Anglani, Mariagiulia, Imbergamo, Silvia, Pravato, Stefano, Marasca, Manuele, Cacciavillani, Mario, Gasparotti, Roberto

Get full text

BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome by Visentin, Andrea, Imbergamo, Silvia, Scomazzon, Edoardo, Pravato, Stefano, Frezzato, Federica, Bonaldi, Laura, Pizzi, Marco, Vio, Stefania, Gregianin, Michele, Burei, Marta, Facco, Monica, Semenzato, Gianpietro, Piazza, Francesco, Trentin, Livio

Get full text

Azathioprine in isolated recurrent pericarditis: A single centre experience by Vianello, Fabrizio, Cinetto, Francesco, Cavraro, Monica, Battisti, Anna, Castelli, Monica, Imbergamo, Silvia, Marcolongo, Renzo

Get full text

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study by Candoni, Anna, Lazzarotto, Davide, Ferrara, Felicetto, Curti, Antonio, Lussana, Federico, Papayannidis, Cristina, Del Principe, Maria Ilaria, Bonifacio, Massimiliano, Mosna, Federico, Delia, Mario, Minetto, Paola, Gottardi, Michele, Fracchiolla, Nicola, Mancini, Valentina, Forghieri, Fabio, Zappasodi, Patrizia, Cerrano, Marco, Vitale, Antonella, Audisio, Ernesta, Trappolini, Silvia, Romani, Claudio, Defina, Marzia, Imbergamo, Silvia, Ciccone, Nadia, Santoro, Lidia, Cambò, Benedetta, Iaccarino, Salvatore, Dargenio, Michela, Aprile, Lara, Chiaretti, Sabina, Fanin, Renato, Pizzolo, Giovanni, Foà, Roberto

“…The outcome of relapsed or refractory (R/R) T‐cell acute lymphoblastic leukemia/lymphoma (T‐ALL/T‐LBL) in adults is poor, with less than 20% of patients…”
Get full text

The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia by Visentin, Andrea, Bonaldi, Laura, Rigolin, Gian Matteo, Mauro, Francesca Romana, Martines, Annalisa, Frezzato, Federica, Imbergamo, Silvia, Scomazzon, Edoardo, Pravato, Stefano, Bardi, Maria Antonella, Cavallari, Maurizio, Volta, Eleonora, Cavazzini, Francesco, Nanni, Maurizio, Del Giudice, Ilaria, Facco, Monica, Guarini, Anna, Semenzato, Gianpietro, Foà, Robin, Cuneo, Antonio, Trentin, Livio

“…Background Complex karyotype (CK) is a heterogeneous category with a negative impact in chronic lymphocytic leukaemia (CLL). Our group has recently reported…”
Get full text

Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients by Visentin, Andrea, Imbergamo, Silvia, Gurrieri, Carmela, Frezzato, Federica, Trimarco, Valentina, Martini, Veronica, Severin, Filippo, Raggi, Flavia, Scomazzon, Edoardo, Facco, Monica, Piazza, Francesco, Semenzato, Gianpietro, Trentin, Livio

“…Abstract Background Major infections (MIs), secondary cancers (SCs) and autoimmune diseases (ADs) are the most common and relevant complications in patients…”
Get full text

Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial by Chiaretti, Sabina, Leoncin, Matteo, Elia, Loredana, Piciocchi, Alfonso, Matarazzo, Mabel, Di Trani, Mariangela, Sica, Simona, Luppi, Mario, Mancini, Valentina, Borlenghi, Erika, Imbergamo, Silvia, Selleri, Carmine, Visani, Giuseppe, Martino, Bruno, Vallisa, Daniele, Vetro, Calogero, Soddu, Stefano, Messina, Monica, Fazi, Paola, Rambaldi, Alessandro, Foà, Robin

“…Introduction. The outcome of Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL) has dramatically improved in the last decade, due with the…”
Get full text

Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience by De Bellis, Eleonora, Imbergamo, Silvia, Candoni, Anna, Liço, Albana, Tanasi, Ilaria, Mauro, Endri, Mosna, Federico, Leoncin, Matteo, Stulle, Manuela, Griguolo, Davide, Pravato, Stefano, Trentin, Livio, Lazzarotto, Davide, Di Bona, Eros, Bassan, Renato, Lucchini, Elisa, Poiani, Monica, Palmieri, Clara, Zaja, Francesco

“…The addition of venetoclax to hypomethylating agents (HMA-V) improved the outcome of patients with newly diagnosed acute myeloid leukemia (AML) ineligible for…”
Get full text

Complex Karyotype Subtypes at Chronic Lymphocytic Leukemia Diagnosis Refine the Risk of Developing a Richter Syndrome. the Richter Syndrome Scoring System by Visentin, Andrea, Rigolin, Gian Matteo, Mauro, Francesca Romana, Martines, Annalisa, Frezzato, Federica, Imbergamo, Silvia, Pravato, Stefano, Romano Gargarella, Leila, Bardi, Maria Antonella, Nanni, Mauro, Piazza, Francesco, Facco, Monica, Foà, Robin, Semenzato, Gianpietro, Bonaldi, Laura, Cuneo, Antonio, Trentin, Livio

“…▪ INTRODUCTION. Richter syndrome (RS), the transformation of chronic lymphocytic leukemia (CLL) into an aggressive lymphoma, is a rare but a life threatening…”
Get full text

Current and future management of Ph/BCR-ABL positive ALL by Maino, Elena, Sancetta, Rosaria, Viero, Piera, Imbergamo, Silvia, Scattolin, Anna Maria, Vespignani, Michele, Bassan, Renato

“…Following the introduction of targeted therapy with tyrosine kinase inhibitors (TKI) at the beginning of the past decade, the outcome of patients with…”
Get full text

Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases by Visentin, Andrea, Imbergamo, Silvia, Frezzato, Federica, Pizzi, Marco, Bertorelle, Roberta, Scomazzon, Edoardo, Berno, Tamara, Riva, Marcello, Piva, Elisa, Facco, Monica, Piazza, Francesco, Semenzato, Gianpietro, Trentin, Livio

“…Hairy cell leukemia variant (HCLv) is a chronic lymphoproliferative disorder classified as a provisional entity in the 2016 WHO Classification of Lymphoid…”
Get full text

Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments by Visentin, Andrea, Facco, Monica, Gurrieri, Carmela, Pagnin, Elisa, Martini, Veronica, Imbergamo, Silvia, Frezzato, Federica, Trimarco, Valentina, Severin, Filippo, Raggi, Flavia, Scomazzon, Edoardo, Pravato, Stefano, Piazza, Francesco, Semenzato, Gianpietro, Trentin, Livio

“…Most important markers in chronic lymphocytic leukemia (CLL) are TP53 abnormalities, including mutations and deletions, and the mutational status of…”
Get full text

Hypometilating Agents (HMA) As Salvage Therapy in Relapsed or Refractory AML: A 5-Center Retrospective Study by Laurino, Marica, Lessi, Federica, Branca, Antonio, Imbergamo, Silvia, Crisà, Elena, Candoni, Anna, Lazzarotto, Davide, Gottardi, Michele, Papayannidis, Cristina, Semenzato, Gianpietro

“…Introduction: 5-azacytidine and decitabine have been widely studied as first line chemotherapy in acute myeloid leukemia (AML) patients not eligible for…”
Get full text